$TFX News

Needham Maintains Buy on Teleflex, Raises Price Target to $159

U.S. FDA Licenses First Freeze-dried Plasma Product Ezplaz In The United States; Ezplaz Available In Group Ab And Group A Low-Titer Anti-B For Emergency Transfusion

UBS Initiates Coverage of Teleflex (TFX) with Neutral Recommendation

UBS Initiates Coverage On Teleflex with Neutral Rating, Announces Price Target of $145

Teleflex Awarded National Premier Contract for Central Venous, Arterial and Intraosseous Access Devices

Mizuho Maintains Neutral on Teleflex, Raises Price Target to $145

BMO Capital Initiates Coverage of Teleflex (TFX) with Outperform Recommendation

BMO Capital Initiates Coverage On Teleflex with Outperform Rating, Announces Price Target of $159

Teleflex Starts Enrollment For Its BIOMAG‑IIII Study Evaluating The Freesolve Resorbable Magnesium Scaffold

Teleflex Presents 4‑Yr Follow‑Up Data From First-in-Human BIOMAG-I Clinical Study At EuroPCR Conference

Piper Sandler Upgrades Teleflex (TFX)

Piper Sandler Upgrades Teleflex to Overweight, Raises Price Target to $160

Teleflex Commences $500M Senior Notes Due 2032 Offering

Teleflex Says Interventional Urology Business Unit Releases New Clinical Data Across Two Major Urological Congresses, Reinforcing Value Of UroLift System And Barrigel Rectal Spacer In Improving Patient-Centered Outcomes

Truist Securities Reiterates Hold on Teleflex, Raises Price Target to $143

RBC Capital Upgrades Teleflex (TFX)

RBC Capital Upgrades Teleflex to Outperform, Raises Price Target to $155

Wells Fargo Maintains Equal-Weight on Teleflex, Raises Price Target to $138

Teleflex (NYSE:TFX) Beats Q1 Estimates and Guides In Line, Stock Surges Pre-Market

Teleflex Incorporated 2026 Q1 - Results - Earnings Call Presentation